Niagen Bioscience (NAGE) vs Prenetics Global (PRE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Prenetics Global (PRE) has outperformed Niagen Bioscience (NAGE) over the past year, gaining 56.3% versus a loss of 62.1%. Over five years, NAGE leads with a -57.2% price change compared with -80.4% for PRE. Prenetics Global is the larger company by market cap ($429.3 million vs $210.5 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAGE | PRE |
|---|---|---|
| Share price | $2.66 | $22.00 |
| Market cap | $210.48M | $429.31M |
| 1-day change | -2.21% | -2.09% |
| YTD return | -57.23% | +42.67% |
| 1-year return | -62.12% | +56.26% |
| 5-year return | -57.23% | -80.42% |
| P/E ratio (TTM) | 14.00 | — |
| Forward P/E | 26.60 | — |
| EPS (TTM) | $0.19 | $-3.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $27.24 |
| 52-week low | $2.61 | $11.37 |
| Distance from 52-week high | -66.54% | -19.24% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +354.14% | +63.00% |
| Average volume | 585.78K | 234.37K |
| Shares outstanding | 79.13M | 17.93M |
| Employees | 117 | 98 |
| Sector | Health Care | Finance |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Prenetics Global is about 2.0 times larger than Niagen Bioscience by market value ($429.31M vs $210.48M).
- PRE has outperformed NAGE by 118.4 percentage points over the past year.
- The two companies sit in different sectors: Niagen Bioscience in Health Care and Prenetics Global in Finance.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
About Prenetics Global
PRE stock →Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.
Finance · Blank Checks · 98 employees
NAGE vs PRE FAQ
Which is bigger, Niagen Bioscience or Prenetics Global?
Prenetics Global (PRE) is larger, with a market capitalization of $429.31M compared with $210.48M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, NAGE or PRE?
PRE returned +56.26% over the past 12 months, compared with -62.12% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Niagen Bioscience and Prenetics Global in the same industry?
No. Niagen Bioscience is in the Health Care sector, while Prenetics Global is in Finance.